Long-term results of percutaneous endoscopic gastrostomies

Yıl 2012, Cilt: 39 Sayı: 2, 162 - 165, 01.06.2012

Murat Çakır Ahmet Tekin Tevfik Küçükkartallar İlhan Çiftçi Celalettin Vatansev Faruk Aksoy Adil Kartal

https://doi.org/10.5798/diclemedj.0921.2012.02.0120

Cited By: 3

Öz

Objectives: In order to provide enteral nutrition for patients in intensive-care units who cannot be fed orally, we aimed to present our percutaneous endoscopic gastrostomy (PEG) experience, which is a minimally invasive method. Materials and methods: In this study, 700 patients who applied to our clinic between January 2000 and June 2011 and who had a PEG because they could not be fed orally were retrospectively assessed in terms of indications, complications, and results. Results: Among these patients, 400 (57%) were male and 300 (43%) were female. Most of the patients with feeding problems had also neurologically caused pathologies. After the PEG, 50 (7.1%) patients had under-skin infections, 18 (2.5%) patients had leakage from the edge of the PEG, and 16 (2.0%) patients had bleeding from the edge of the PEG. Conclusion: PEG is a secure and effective nutrition method as it can be performed with a minimally invasive procedure and it has low mortality and morbidity.

Anahtar Kelimeler

Gastrostomy, enteral nutrition, endoscopy

Perkütan endoskopik gastrostomi uyguladığımız hastalarda uzun dönem sonuçlarımız

Öz

Amaç: Oral gıda alamayan, özellikle yoğun bakım ünitelerinde yatmakta olan hastalara enteral beslenme desteği sağlamak amacıyla minimal invaziv bir metod olan perkutan endoskopik gastrostomi (PEG) deneyimimizi sunmayı amaçladık. Gereç ve yöntem: Bu çalışmada kliniğimizde Ocak 2000 - Haziran 2010 tarihleri arasında en az 4 hafta süreyle oral beslenemeyeceği öngörülerek PEG yerleştirilen 700 olgu retrospektif olarak incelendi. Hasta kayıtları endikasyonlar, komplikasyonlar ve sonuçları açısından değerlendirildi. Bulgular: Hastaların 400\' (% 57) ü erkek, 300\' ü (%43) bayandı. Olguların büyük çoğunluğu nörolojik nedenli patolojilerdi. Tüm hastalarda beslenme problemi vardı. PEG sonrası 50 (%7.1) hastada cilt altı infeksiyonu, 18 (%2.5) hastada PEG kenarından kaçak, 16 (%2.0) hastada PEG kenarından kanama görüldü. Sonuç: PEG, minimal invaziv bir girişim ile yapılabilmesi, mortalite ve morbiditesinin çok az olması nedeniyle yoğun bakım hastaları için basit, emniyetli ve etkili bir beslenme yöntemidir.

Anahtar Kelimeler

Endoskopik gastrostomi, enteral beslenme, endoskopi

Kaynakça

• Hamidon BB, Abdullah SA, Zawawi MF, Sukumar N, Ami- nuddin A, Raymond AA. A prospective comparison of per- cutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with acute dysphagic stroke. Med J Ma- laysia 2006;61(1):59-66.
• Cantwell CP, Gervais DA, Hahn PF, Mueller PR. Feasibil- ity and safety of infracolic fluoroscopically guided per- cutaneous radiologic gastrostomy. J Vasc Interv Radiol 2008;19(1):129-32.
• Gauderer MW, Ponsky JL, Izant RJ Jr.Gastrostomy without laparotomy: a percutaneous endoscopic technique. 1980. Nutrition 1998;14(9):736-8.
• Nicholson FB, Korman MG, Richardson MA. Percutaneous endoscopic gastrostomy: a review of indications, complica- tions and outcome. J Gastroenterol Hepatol 2000;15(1):21- 5.
• Rabeneck L, Wray NP, Petersen NJ. Long-term outcomes of patients receiving percutaneous endoscopic gastrostomy tubes. J Gen Intern Med 1996;11(5):287-93.
• Stockeld D, Fagerberg J, Granström L, Backman L. Percuta- neous endoscopic gastrostomy for nutrition in patients with oesophageal cancer. Eur J Surg 2001;167(11):839-44.
• Potochny JD, Sataloff DM, Spiegel JR, Lieber CP, Siskind B, Sataloff RT. Head and neck cancer implantation at the per- cutaneous endoscopic gastrostomy exit site. A case report and a review. Surg Endosc 1998;12(11):1361-5.
• Saadeddin A, Freshwater DA, Fisher NC, Jones BJ. Antibi- otic prophylaxis for percutaneous endoscopic gastrostomy for non-malignant conditions: a double-blind prospec- tive randomized controlled trial. Aliment Pharmacol Ther 2005;22(6):565-70.
• Robins G, Hull M. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy insertion in patients with non-ma- lignant disease. Aliment Pharmacol Ther 2006;23(8):1276- 7; author reply 1277.
• Sturgis TM, Yancy W, Cole JC, Proctor DD, Minhas BS, Marcuard SP. Antibiotic prophylaxis in percutaneous endo- scopic gastrostomy. Am J Gastroenterol 1996;91(11):2301- 4.
• Rey JR, Axon A, Budzynska A, Kruse A, Nowak A. Guide- lines of the European Society of Gastrointestinal Endosco- py (E.S.G.E.) antibiotic prophylaxis for gastrointestinal en- doscopy. European Society of Gastrointestinal Endoscopy. Endoscopy 1998;30(3):318-24.
• Hameed H, Khan YI.Metastasis of carcinosarcoma of oe- sophagus to gastrostomy site. Br J Oral Maxillofac Surg 2009;47(8):643-4.
• Vatansev C, Aksoy F, Belviranlı M, Yosunkaya A, Özer S. Yoğun bakım hastalarında perkütan endoskopik gastrosto- mi. Endoskopik Laparoskopik ve Mminimal İnvaziv Cerra- hi 2002;9(4):69-72.
• Stein J, Schulte-Bockholt A, Sabin M, Keymling M. A ran- domized prospective trial of immediate vs. next-day feed- ing after percutaneous endoscopic gastrostomy in intensive care patients. Intensive Care Med 2002;28(11):1656-60.